Here’s how Ohio State plans to support more startups – Bizwomen – The Business Journals

Related Articles:

• Monthy research review – December 2019 December 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – November 2020 November 30, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Monthly research review – October 2019 October 31, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Monthly Research Review: Jaunary 2020 January 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2020. The post is divided into seven parts based on the type of research: Basic biology, Disease mechanism, Clinical research, New clinical trials, Clinical trial news, Other news, and…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• Monthly Research Review – September 2019 September 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – November 2019 November 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
• Eva Longoria, Cheetos, and an American success story - Bizwomen - The Business Journals August 30, 2019 Eva Longoria, Cheetos, and an American success story - Bizwomen  The Business JournalsThe actress is directing a film about the spicy snack's inventor.
• Monthly Research Review – August 2019 August 31, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during August 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Medicare Coverage and Parkinson’s February 7, 2019 Written by Danielle Kunkle Roberts, Forbes Finance Council member and co-owner of Boomer Benefits No one plans to spend their retirement battling a chronic illness, yet people on Medicare are diagnosed with such illnesses all the time. Dealing with a progressive chronic condition like Parkinson’s can be particularly devastating and also expensive. Parkinson’s affects more than one million people in…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• ReWriting the World February 16, 2020 The following is an expanded version of a piece that recently appeared in Times Higher Education. It was written with Prof. Hilal A. Lashuel, the director of the laboratory of molecular and chemical biology of neurodegeneration at the Swiss Federal Institute of Technology Lausanne (École Polytechnique Federale de Lausanne, EPFL).     “That’s it, that’s the cure.” I stood squinting at…
• ReWriting the World February 16, 2020 The following is an expanded version of a piece that recently appeared in Times Higher Education. It was written with Prof. Hilal A. Lashuel, the director of the laboratory of molecular and chemical biology of neurodegeneration at the Swiss Federal Institute of Technology Lausanne (École Polytechnique Federale de Lausanne, EPFL).     “That’s it, that’s the cure.” I stood squinting at…
• ReWriting the World February 16, 2020 The following is an expanded version of a piece that recently appeared in Times Higher Education. It was written with Prof. Hilal A. Lashuel, the director of the laboratory of molecular and chemical biology of neurodegeneration at the Swiss Federal Institute of Technology Lausanne (École Polytechnique Federale de Lausanne, EPFL).     “That’s it, that’s the cure.” I stood squinting at…